The positive doping test from Brazilian Olympic Team member Etiene Medeiros may be the result of an error in her paperwork for a Therapeutic Use Exemption (TUE) on an asthma drug, according to a Brazilian reporter.
According to BestSwimming.br, Medeiros tested positive for the substance fenbuterol, which is used to treat asthma. Medeiros also scratched out of the Mare Nostrum series last week based on complications associated with asthma.
Now Alex Pussieldi, a coach who covers swimming for BestSwimming.br, has said via Twitter that Medeiros’ positive test appears to be the result of a mistake in registering the substance in her anti-doping paperwork.
“The Etiene Medeiros doping case seems an easy resolution,” a rough translation of his tweet (written in Portuguese) says. “It was a mistake in filling out the TUE – Therapeutic Use Exemption.”
Athletes who take prescribed medication to deal with conditions like asthma are allowed to file for TUEs in their anti-doping paperwork. Those medications can contain substances that are otherwise banned, but if an athlete can prove they require that medication to treat a medical issue, they can be given a therapeutic use exemption and be allowed to have the substance in their system.
Pussieldi also tweeted that the Brazilian swimming federation was likely to issue a statement today, and that Medeiros’ lawyer, Marcelo Franklin, has proven capable in these types of cases in the past.
Medeiros was in line to swim the 50 free, 100 free and 100 back at the home Olympic Games in Rio de Janeiro this summer. She could now be facing a suspension that takes her out of commission for those Olympics.